LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Maiden Holdings, Ltd. To Contact The Firm
If you invested in Maiden stock or options between
You can also contact us by calling
The lawsuit has been filed in the
The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to accurately represent the quality and nature of Maiden’s underwriting and risk management policies and practices and the risks of its reinsurance portfolio. In reality, the Company had failed to employ sufficient underwriting and risk management protocols and had largely abdicated its responsibility to ensure that its AmTrust Reinsurance segment priced policies commensurate with the risk assumed by the Company.
As the Company’s fraud was gradually revealed through several corrective disclosures, Maiden’s share price declined significantly, causing harm to investors.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190329005512/en/
Attn:
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330
Source:
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Health Insurance Innovations, Inc.
Georgia lawmakers approve ‘heartbeat’ abortion ban
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News